scholarly journals Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease

2011 ◽  
Vol 188 (3) ◽  
pp. 1136-1146 ◽  
Author(s):  
Marianna Ioannou ◽  
Themis Alissafi ◽  
Iakovos Lazaridis ◽  
George Deraos ◽  
John Matsoukas ◽  
...  
2014 ◽  
Vol 192 (3) ◽  
pp. 1334-1334
Author(s):  
Marianna Ioannou ◽  
Themis Alissafi ◽  
Iakovos Lazaridis ◽  
George Deraos ◽  
John Matsoukas ◽  
...  

2018 ◽  
Vol 19 (12) ◽  
pp. 1341-1351 ◽  
Author(s):  
Benjamin Knier ◽  
Michael Hiltensperger ◽  
Christopher Sie ◽  
Lilian Aly ◽  
Gildas Lepennetier ◽  
...  

1996 ◽  
Vol 28 (2) ◽  
pp. 83-97 ◽  
Author(s):  
Jan Bauer ◽  
Sigrid R. Ruuls ◽  
Ingeborg Huitinga ◽  
Christine D. Dijkstra

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Wenjing Cheng ◽  
Guangjie Chen

Multiple sclerosis is an autoimmune disease with classical traits of demyelination, axonal damage, and neurodegeneration. The migration of autoimmune T cells and macrophages from blood to central nervous system as well as the destruction of blood brain barrier are thought to be the major processes in the development of this disease. Chemokines, which are small peptide mediators, can attract pathogenic cells to the sites of inflammation. Each helper T cell subset expresses different chemokine receptors so as to exert their different functions in the pathogenesis of MS. Recently published results have shown that the levels of some chemokines and chemokine receptors are increased in blood and cerebrospinal fluid of MS patients. This review describes the advanced researches on the role of chemokines and chemokine receptors in the development of MS and discusses the potential therapy of this disease targeting the chemokine network.


2013 ◽  
Vol 190 (5) ◽  
pp. 1948-1960 ◽  
Author(s):  
Vrajesh V. Parekh ◽  
Lan Wu ◽  
Danyvid Olivares-Villagómez ◽  
Keith T. Wilson ◽  
Luc Van Kaer

2018 ◽  
Vol 19 (8) ◽  
pp. 2408 ◽  
Author(s):  
Patrizia LoPresti

Oligodendrocytes (OLGs), the myelin-forming cells of the central nervous system (CNS), are lifelong partners of neurons. They adjust to the functional demands of neurons over the course of a lifetime to meet the functional needs of a healthy CNS. When this functional interplay breaks down, CNS degeneration follows. OLG processes are essential features for OLGs being able to connect with the neurons. As many as fifty cellular processes from a single OLG reach and wrap an equal number of axonal segments. The cellular processes extend to meet and wrap axonal segments with myelin. Further, transport regulation, which is critical for myelination, takes place within the cellular processes. Because the microtubule-associated protein tau plays a crucial role in cellular process extension and myelination, alterations of tau in OLGs have deleterious effects, resulting in neuronal malfunction and CNS degeneration. Here, we review current concepts on the lifelong role of OLGs and myelin for brain health and plasticity. We present key studies of tau in OLGs and select important studies of tau in neurons. The extensive work on tau in neurons has considerably advanced our understanding of how tau promotes either health or disease. Because OLGs are crucial to neuronal health at any age, an understanding of the functions and regulation of tau in OLGs could uncover new therapeutics for selective CNS neurodegenerative diseases.


Sign in / Sign up

Export Citation Format

Share Document